Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH

Hepatology(2021)10.1002/hep.32274Source: DataRank Database

NASHFit: A randomized controlled trial of an exercise training program to reduce clotting risk in patients with NASH is a research paper published in Hepatology (2021). On theSindex it has a DataRank of 0. It has been cited 62 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access62 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.71)OA: greenTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Ian Schreibman,Alison Faust ORCID,Jessica Dahmus ORCID,B. Stern ORCID,Christopher Soriano ORCID

Live enrichment

PubMed:34890063 PMC:PMC9184303 OpenAlex:https://openalex.org/W4200179395

NCATS NIH HHS

Grant: UL1 TR000127

NCATS NIH HHS

Grant: UL1 TR002014

NIDDK NIH HHS

Grant: L30 DK118601

Pennsylvania Department of Health

FWCI

4.71

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: http://doi.wiley.com/10.1002/tdm_license_1.1

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9184303

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32274

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/hep.32274

publisherhttps://journals.lww.com/10.1002/hep.32274

Fields of Study

Liver Disease Diagnosis and TreatmentLipid metabolism and disordersLiver Disease and TransplantationExerciseHumansMagnetic Resonance ImagingNon-alcoholic Fatty Liver DiseasePlasminogen Activator Inhibitor 1Thrombosis

MeSH Terms

HumansMagnetic Resonance ImagingThrombosisExercisePlasminogen Activator Inhibitor 1Non-alcoholic Fatty Liver Disease

Keywords

MedicineRandomized controlled trialClinical endpointClinical trialInternal medicineVO2 maxStandard errorPhysical therapyTissue plasminogen activatorBiomarkerBlood pressureHeart rate

Sustainable Development Goals

SDG 0: Good health and well-being